Update
$Allakos(ALLK.US$ Reuters· 4 mins ago
Allakos Announces Positive Results From Its Ongoing Phase 1 Trial of Ak006 in Healthy Volunteers, With Ak006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile
Allakos Announces Positive Results From Its Ongoing Phase 1 Trial of Ak006 in Healthy Volunteers, With Ak006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
